ATRY (ATRY) News
Follow ATRY (ATRY) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
ATRY revenue up 9.4% in 1H 2026 as EBITDA rises 21.3%
ATRY reported revenue up 9.4% year-over-year in 1H 2026. The company said EBITDA rose 21.3% and net debt fell 79.2% after divesting its Prevention Division.
EARNINGS | Sep 10, 2026, 02:13 PM UTC
L
Atrys reports H1 2026 revenue up 9.4% and EBITDA up 21.3%
Atrys Health reported H1 2026 revenue of €77.7M, up 9.4%, with EBITDA up 21.3%. The company said net debt fell 79.2% after the ASPY sale and that full-year guidance was reaffirmed.
EARNINGS | Sep 10, 2026, 07:48 AM UTC
L
ATRY reports 1H 2026 revenue growth and EBITDA rise YoY
Atrys Health SA said 1H 2026 revenue grew YoY to €77.7M and EBITDA rose YoY. Net debt fell 79.2% after the Prevention segment sale; 2026 guidance was reaffirmed.
EARNINGS | Sep 10, 2026, 06:39 AM UTC
L
Atrys H1 Net Loss At €6.4 Mln
Atrys Health SA BME:ATRY:Source text
EQUITY | Sep 10, 2026, 06:28 AM UTC